• Follow Us:

High-level Meeting on Antimicrobial Resistance convened by the President of the General Assembly

Details

High-level Meeting on Antimicrobial Resistance convened by the President of the General Assembly

High-level Meeting on Antimicrobial Resistance convened by the President of the General Assembly. Theme: Investing in the present and securing our future together: accelerating multi-sectoral global, regional and national actions to address antimicrobial resistance. Drug-resistant infections know no borders, meaning no single country can respond to AMR alone.

Watch Live UN WEB TV: https://webtv.un.org/en/asset/k11/k11knc6w2t

The High-level Meeting consist of an opening segment, a plenary, two interactive multi-stakeholder panels, and a closing segment.

Panel 1: Address the urgent antimicrobial resistance crisis across the human, animal, plant, and environmental sectors through equity, access, building awareness, and innovation.

Panel 2: Human health, animal health and welfare, agrifood systems, and protecting the environment to tackle antimicrobial resistance, through integrated surveillance, capacity-building, sustainable resources, financing, and investment.

The high-level meeting is expected to approve a concise and action-oriented political declaration with a shared vision including the consideration of measurable targets and objectives on mobilizing political will and action to address the drivers, sources and challenges of antimicrobial resistance, agreed in advance by consensus through intergovernmental negotiations, to be submitted by the President of the General Assembly for adoption by the Assembly.

In 2016 the first high-level meeting on AMR resulted in a political declaration that laid the foundation for global action against Antimicrobial Resistance (AMR). According to the World Health Organization, AMR is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019

The World Bank estimates that it could result in US$ 1 trillion additional healthcare costs by 2050, and up to US$ 3.4 trillion gross domestic product (GDP) losses per year by 2030.

One Health Society received aspecial accreditation to attend in person the United Nations General Assembly (UNGA79) High level meeting on Antimicrobial Resistance and Science Summit in New York, USA. Our participation in this event will provide invaluable insights and opportunities to further our collective efforts in promoting global health agendas.

Leveraging the presence of our newly formed Tanzania Parliamentarian Alliance for AMR, We have secured two seats for the chairperson and the secretary of the Tanzania Parliamentarians Alliance to Attend The United Nations General Assembly (UNGA79) High Level Meeting On Antimicrobial Resistance And Science Summit. This will showcase our effort to engage policymakers in the fight against AMR.

#OneHealthTz  #MPsAMRAlliance #UNGA79 #ScienceSummit

  • Share:
WhatsApp